Abstract
Nineteen unselected patients undergoing subtotal thyroidectomy (STT) for Graves' disease were submitted to thorough ophthalmologic assessment before and after (mean, 10 mo) thyroid surgery. All clinical examinations were performed by the same observer and findings were scored according to the American Thyroid Association (“NOSPECS”) classification. Orbital computed tomography (CT) scans were performed in all patients prior to surgery and again at follow-up if the initial scan was abnormal or if there was evidence of clinical deterioration; all CT scans were viewed by the same individual. There was evidence of infiltrative ophthalmopathy at some stage in the course of observation in 17 (89%) of the 19 patients.
No predictable ocular response to STT was apparent. Ophthalmic status was noted to improve in 6 patients, to remain unchanged in 7 patients, and to progressively deteriorate in 6 patients. This unpredictable pattern was seen irrespective of the severity of preexisting ocular involvement. The absence of any consistent or predictable ocular response to STT strongly suggests that thyroidectomy does not influence the natural course of Graves' ophthalmopathy. We believe that the presence of evolving or stable ophthalmopathy, even if severe, should not be regarded as a contraindication to STT in Graves' disease.
Résumé
Dix-neuf patients non sélectionnés ont eu une évaluation ophthalmologique avant et après (moyenne, 10 mois) une thyroïdectomie subtotale (TST) pour maladie de Basedow. Tous les examens ont été faits par le même médecin, et les résultats ont été notés selon la classification “NOSPECS” de l'American Thyroid Association. Une tomodensitométrie (TDM) orbitale a été effectuée chez tous les patients avant la thyroïdectomie et une fois encore après si l'examen initial était anormal, ou si l'état clinique s'aggravait. Tous les résultats de TDM orbitale ont été interprétés par le même médecin. Dix-sept (89%) des 19 patients avaient une ophtalmopathie infiltrative à un moment donné de l'évolution.
On n'a pas mis en évidence de réponse oculaire à la TST. L'état ophtalmique s'est amélioré chez 6 patients, est resté inchangé chez 7, et s'est détérioré chez les 6 autres. L'évolution ophtalmique était imprévisible quelle que soit la sévérité de l'état ophtalmique préexistant. L'absence de réponse oculaire constante ou prévisible dans cette série suggère fortement que la thyroïdectomie n'influe pas sur l'évolution naturelle de l'ophtalmopathie de la maladie de Basedow. Nous croyons que la présence d'ophtalmopathie, stable ou pas, même si elle est sévère, ne devrait pas constituer une contre-indication à la TST dans la maladie de Basedow.
Resumen
Diecinueve patientes no seleccionados sometidos a tiroidectomía subtotal (TST) por enfermedad de Graves fueron llevados a una completa valoración oftalmológica antes y después (promedio, 10 meses) de la cirugía tiroidea. Todos los exámenes clínicos fueron realizados por el mismo observador y los hallazgos fueron registrados de acuerdo con la clasificación de la Asociación Americana de Tiroides (“NOSPECS”). Se hicieron tomografías computadorizadas (TC) orbitales en todos los pacientes antes de la cirugía y en el período de seguimiento si la escanografía inicial era anormal o si había evidencia de deterioro clínico; todas las TC fueron interpretadas por la misma persona. Se halló evidencia de oftalmopatía infiltrativa en algún momento en el curso de la observación en 17 (89%) de los 19 pacientes.
Ninguna respuesta ocular predecible a la TST se hizo aparente. El estado oftálmico mejoró en 6 pacientes, permaneció sin cambio en 7, y se deterioró en forma progresiva en 6. Este impredecible patrón fue observado con independencia de la gravedad de la afección ocular preexistente. La ausencia de una respuesta ocular predecible o consistente a la TST ciertamente sugiere que la tiroidectomía no influencia la evolutión natural de la oftalmopatía de Graves. Creemos que la presencia de una oftalmopatía estable o en evolución, aún si es severa, no debe ser considerada como contraindicatión para la TST en la enfermedad de Graves.
Similar content being viewed by others
References
Naffziger, H.C.: Progressive exophthalmos following thyroidectomy; its pathology and treatment. Ann. Surg.94:582, 1931
Means, J.H.: The nature of Graves' disease with special reference to its ophthalmic component. Am. J. Med. Sci.207:1, 1944
McGill, D.A., Asper, S.P.: Endocrine exophthalmos. A review and a report on autoantibody studies. N. Engl. J. Med.267:188, 1962
Gott, P.H.: Treatment of Graves' disease. (Letter). J.A.M.A.244:1558, 1980
Soley, M.H.: Exophthalmos in patients with various types of goiter. Arch. Intern. Med.70:206, 1942
Dobyns, B.M.: The influence of thyroidectomy on the prominence of the eyes in the guinea pig and in man. Surg. Gynecol. Obstet.80:526, 1945
Dobyns, M., Haines, S.F.: Changes in the prominence of the eyes in various thyroid states. J. Clin. Endocrinol.6:633, 1946
Lamberg, B.-A.: The thyro-hypophysial syndrome. I. The primary reaction of the hypophysial eye signs (including exophthalmos) to the treatment of thyrotoxicosis. Acta Med. Scand.148:225, 1954
Catz, B., Perzik, S.L.: Subtotal vs. total surgical ablation of the thyroid, malignant exophthalmos and its relation to remnant thyroid. In Current Topics in Thyroid Research, C. Cassano, M. Andreoli, editors, New York, Academic Press, 1965
Kirmse, L., Lahrtz, H., Schemmel, K., Waschulzik, G., Muller, W., Uthgenannt, H., Weissbecker, L.: Treatment of progressive malignant exophthalmos by total thyroidectomy. Acta Endocrinol.173:[Supp.]:24, 1973
Perzik, S.L.: Total thyroidectomy in Graves' disease in children. J. Pediatr. Surg.11:191, 1976
Bauer, F.K., Catz, B.: Radioactive iodine therapy for progressive malignant exophthalmos. Acta Endocrinol.51:15, 1966
White, I.L.: Total thyroid ablation: A prerequisite to orbital decompression for Graves' disease ophthalmopathy. Laryngoscope84:1869, 1974
Muller, W., Schemmel, K., Uthgenannt, H., Weissbecker, L.: Die behandlung des malignen exophthalmus durch totale thyreoidektomie. Dtsch. Med. Wochenschr.46:2103, 1967
Rundle, F.F., Wilson, C.W.: Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clin. Sci.5:177, 1944
Hales, I.B., Rundle, F.F.: Ocular changes in Graves' disease. A long-term follow-up study. Q. J. Med.29:113, 1960
Hamilton, R.D., Mayberry, W.E., McConahey, W.M., Hanson, K.C.: Ophthalmopathy of Graves' disease: A comparison between patients treated surgically and patients treated with radioiodide. Mayo Clin. Proc.42:812, 1967
Ingbar, S.H., Woeder, K.A.: The thyroid gland. In Textbook of Endocrinology, R.H. Williams, editor, Philadelphia, W.B. Saunders, 1981, pp. 200–201
Werner, S.C.: Modification of the classification of the eye changes of Graves' disease: Recommendations of the ad hoc committee of the American Thyroid Association (Letter). J. Clin. Endocrinol. Metab.44:203, 1977
Werner, S.C., Feind, C.R., Aida, M.: Graves' disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long-acting thyroid stimulator after operation. N. Engl. J. Med.276:132, 1967
Beierwaltes, W.H.: Exophthalmos and thiouracil therapy. Arch. Intern. Med.81:364, 1948
Duke-Elder, S., MacFaul, P.A.: Orbital involvement in general disease. In System of Ophthalmology, vol. 13, no. 2, S. Duke-Elder, editor, London, Henry Kimpton, 1974
Gwinup, G., Elias, A.N., Ascher, M.S.: Effect on exophthalmos of various methods of treatment of Graves' disease. J.A.M.A.247:2135, 1982
Pequegnat, E.P., Wayberry, W.E., McConahey, W.M., Wyse, E.P.: Large doses of radioiodide in Graves' disease: Effect on ophthalmopathy and long-acting thyroid stimulator. Mayo Clin. Proc.42:802, 1967
Jones, D.I.R., Munro, D.S., Wilson, G.M.: Observations on the course of exophthalmos after I-131 therapy. Proc. R. Soc. Med.62:15, 1969
Stockigt, J.R., Topliss, D.J.: Diagnosis and management of hyperthyroidism. Med. J. Aust.145:218, 1986
Gorman, C.A.: Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin. Proc.58:515, 1983
Agapitos, P.J., Hart, I.R.: Long-term follow-up of ophthalmic Graves' disease. Can. Med. Assoc. J.136:369, 1987
Solomon, D.H., Chopra, I.J., Chopra, U., Smith, F.J.: Identification of subgroups of Graves' ophthalmopathy. N. Engl. J. Med.296:181, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levitt, M.D., Edis, A.J., Agnello, R. et al. The effect of subtotal thyroidectomy on Graves' ophthalmopathy. World J. Surg. 12, 593–596 (1988). https://doi.org/10.1007/BF01655858
Issue Date:
DOI: https://doi.org/10.1007/BF01655858